Meredith Mudgett-Hunter

Title: The Innovative Contributions of Meredith Mudgett-Hunter

Introduction

Meredith Mudgett-Hunter is a notable inventor based in Hyde Park, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 3 patents, her work has implications for both therapeutic and diagnostic applications.

Latest Patents

One of her latest patents is focused on monoclonal antidigoxin antibodies. This invention discloses a hybridoma culture and high-affinity monoclonal antidigoxin antibodies produced by somatic cell fusion. These antibodies are useful for therapeutic purposes as well as for diagnostic applications. They also serve as a model system for studying structure-function relationships in antigen-antibody specific reactions. Another significant patent is for a monoclonal antibody to Mullerian inhibiting substance. This method involves preparing a monoclonal hybridoma that secretes antibodies against an immunogenic material. The process includes sensitizing a source with an immunizing amount of the material, obtaining lymphocytes with immune activity, and fusing them with an appropriate cell line to form mixed hybridomas.

Career Highlights

Meredith Mudgett-Hunter is currently associated with The General Hospital Corporation, where she continues her innovative work in biotechnology. Her research has contributed to advancements in medical diagnostics and therapeutics.

Collaborations

Some of her notable coworkers include Patricia K Donahoe and Gerald P Budzik, who have collaborated with her on various projects.

Conclusion

Meredith Mudgett-Hunter's contributions to the field of biotechnology through her patents and research are commendable. Her work continues to impact the medical field positively, showcasing the importance of innovation in science.